German University in Cairo: Clinical Trials

13 trials sponsored by German University in Cairo, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 unknown, 4 completed, 2 recruiting, 1 not yet recruiting. 10 Phase 2, 1 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 210Unknown 4, Completed 3, Recruiting 2, Not yet recruiting 1
Phase 11Unknown 1
Phase 31Unknown 1

Follow German University in Cairo: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effect of Add-on L-Arginine Therapy on Heart Failure Patients
L-Arginine Powder, Placebo - Heart Failure
Phase 2Not yet recruitingGerman University in Cairo2002026-02-012026-02-06
Evaluation of the Effect of L-Arginine on the Cognitive Function in Geriatric Patients
L-Arginine, Placebo - Cognition Disorders in Old Age, Cognitive and Behavioral Impairment
Phase 2RecruitingGerman University in Cairo602025-08-272026-01-21
L-carnitine Supplementation in Rheumatoid Arthritis Patients
Carnitine, Disease-modifying anti-rheumatic drugs - Rheumatoid Arthritis (RA)
Phase 2RecruitingGerman University in Cairo602024-12-312025-01-07
Effect of Vitamin D Supplementation on Mental Health: An Exploratory Study on A University Students Suffering From Vitamin D Deficiency
Vit D, Placebo - Psychiatric Disorder
Phase 1 / Phase 2UnknownGerman University in Cairo702024-06-302024-06-13
Clinical Evaluation of the Effect of Metformin in Sepsis
Metformin - Sepsis
Phase 3UnknownGerman University in Cairo1102023-09-102023-09-13
Evaluation of the Effect of Nigella Sativa for the Prophylaxis to Radiation Induced Dermatitis in Breast Cancer Patients
Imtenan Oil, Baraka Capsules - Radiation Dermatitis
Phase 2CompletedGerman University in Cairo1322023-01-242024-02-23
Expression of microRNA-133a and microRNA-208b in Acute Myocardial Infarction
No intervention - Myocardial Infarction, Acute
CompletedIslamia University of Bahawalpur102022-12-282023-01-20
Effect of Topical Diclofenac on Clinical Outcome in Breast Cancer Patients Treated With Capecitabine
(CARBAMIDE®), (VOLTAREN®) Emulgel 1% - Hand and Foot Syndrome
Phase 2CompletedGerman University in Cairo862022-12-082024-01-03
The Effect of Metformin As an Adjuvant Therapy on Immunological Parameters in Egyptian Patients with RRMS: a Pilot Study
Metformin (Cidophage®), Usual Care - Multiple Sclerosis (MS) - Relapsing-remitting
Phase 2CompletedGerman University in Cairo302022-04-012025-02-06
The Impact of Body Weight on Clinical and Immunological Outcomes in Relapse-Remitting Multiple Sclerosis Patients
Blood sample collection - Multiple Sclerosis
UnknownGerman University in Cairo1382022-02-012023-12-19
Drug Repurposing Using Metformin for Improving the Therapeutic Outcome in Multiple Sclerosis Patients
MetFORMIN 1000 Mg Oral Tablet, Interferon beta-1a - Multiple Sclerosis
Phase 2UnknownGerman University in Cairo802022-02-012023-03-20
Evaluation of the Effect of Rosuvastatin on Cisplatin-induced Nephrotoxicity and Ototoxicity
Rosuvastatin 10mg - Cisplatin Adverse Reaction
Phase 2UnknownCairo University652020-11-172021-07-28
Drug Repurposing for the Prevention of Chemotherapy-induced Peripheral Neuropathy (CIPN)
Metformin, Placebo - Chemotherapy-induced Peripheral Neuropathy
Phase 2UnknownCairo University682020-11-032021-07-28

Conditions studied

Breast Neoplasms (2)  ·  Multiple Sclerosis (2)  ·  Arthritis, Rheumatoid (1)  ·  Cognitive Dysfunction (1)  ·  Hand-Foot Syndrome (1)  ·  Heart Failure (1)  ·  Mental Disorders (1)  ·  Multiple Sclerosis, Relapsing-Remitting (1)  ·  Myocardial Infarction (1)  ·  Neoplasms (1)  ·  Ototoxicity (1)  ·  Radiodermatitis (1)  ·  Sepsis (1)

Interventions

Metformin (4)  ·  Antirheumatic Agents (1)  ·  Arginine (1)  ·  Carnitine (1)  ·  Diclofenac (1)  ·  Interferon beta-1a (1)  ·  Rosuvastatin Calcium (1)  ·  Tablets (1)  ·  Urea (1)

Countries

Egypt (12)

Top investigators

Aya T Moustafa, BSc (1)  ·  Dalia S Elhelw, PhD (1)  ·  Danira Ashraf Habashy, PhD Pharm. (1)  ·  Hafiz A Sattar, M.Phil (1)  ·  Loay Kassem, PhD (1)  ·  Loay M. Kassem, PhD (1)  ·  Mayar Waleed Salaheldin Aly, M.Sc. (1)  ·  Mohamed H Solayman, PhD (1)  ·  Mohamed H. Solayman, PhD. Pharm. (1)  ·  Sally I Hassanien, Ph.D (1)  ·  Sara A. Mosa, Bsc (1)

Results publications

PMID 24733808, PMID 38070031, PMID 41483718